As of May 26
| -0.04 / -1.29%|
The 5 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.50. The median estimate represents a +96.08% increase from the last price of 3.06.
The current consensus among 7 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.